These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8809423)

  • 1. Eosinophil locomotion and the release of IL-3 and IL-5 by allergen-stimulated mononuclear cells are effectively downregulated in vitro by budesonide.
    Lantero S; Sacco O; Scala C; Morelli MC; Rossi GA
    Clin Exp Allergy; 1996 Jun; 26(6):656-64. PubMed ID: 8809423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the inhibitory effects of budesonide on the mitogen-induced or the allergen-induced activation of blood mononuclear cells isolated from asthmatic patients.
    Oddera S; Silvestri M; Sacco O; Lantero S; Morelli MC; Rossi GA
    Ann Allergy Asthma Immunol; 1995 Jul; 75(1):33-40. PubMed ID: 7621058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of blood mononuclear cells of atopic children with the relevant allergen induces the release of eosinophil chemotaxins such as IL-3, IL-5, and GM-CSF.
    Lantero S; Sacco O; Scala C; Rossi GA
    J Asthma; 1997; 34(2):141-52. PubMed ID: 9088301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration-dependent activity of mometasone furoate and dexamethasone on blood eosinophils isolated from atopic children: modulation of Mac-1 expression and chemotaxis.
    Sale R; Sabatini F; Silvestri M; Serpero L; Petecchia L; Rossi GA
    Int Immunopharmacol; 2004 Dec; 4(13):1687-96. PubMed ID: 15454120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The topical glucocorticoids beclomethasone dipropionate and fluticasone propionate inhibit human T-cell allergen-induced production of IL-5, IL-3 and GM-CSF mRNA and protein.
    Powell N; Till SJ; Kay AB; Corrigan CJ
    Clin Exp Allergy; 2001 Jan; 31(1):69-76. PubMed ID: 11167953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte function in the airways of allergen-challenged pigs: effects of inhaled and systemic budesonide.
    Fornhem C; Peterson CG; Dahlbäck M; Scheynius A; Alving K
    Clin Exp Allergy; 1996 Dec; 26(12):1436-48. PubMed ID: 9027445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide down-regulates eosinophil locomotion but has no effects on ECP release or on H2O2 production.
    Lantero S; Oddera S; Silvestri M; Gonzalez Rodriguez R; Morelli MC; Rossi GA
    Lung; 1999; 177(4):219-28. PubMed ID: 10384060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
    Wang LH; Lin YH; Yang J; Guo W
    Int Arch Allergy Immunol; 2009; 148(3):199-210. PubMed ID: 18849611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ CD30+ T cells perpetuate IL-5 production in Dermatophagoides pteronyssinus allergic patients.
    Garfias Y; Ortiz B; Hernández J; Magaña D; Becerril-Angeles M; Zenteno E; Lascurain R
    Allergy; 2006 Jan; 61(1):27-34. PubMed ID: 16364153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The release of eosinophil chemotactic activity and eosinophil chemokinesis inhibitory activity by mononuclear cells from atopic asthmatic and non-atopic subjects.
    Grzegorczyk J; Majkowska-Wojciechowska B; Kowalski ML
    Mediators Inflamm; 2000; 9(1):7-13. PubMed ID: 10877449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium.
    Mullol J; López E; Roca-Ferrer J; Xaubet A; Pujols L; Fernàndez-Morata JC; Fabra JM; Picado C
    Clin Exp Allergy; 1997 Dec; 27(12):1432-41. PubMed ID: 9433939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-5 receptors on human lung eosinophils after segmental allergen challenge.
    Julius P; Hochheim D; Böser K; Schmidt S; Myrtek D; Bachert C; Luttmann W; Virchow JC
    Clin Exp Allergy; 2004 Jul; 34(7):1064-70. PubMed ID: 15248851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro.
    Solomon A; Shmilowich R; Shasha D; Frucht-Pery J; Pe'er J; Bonini S; Levi-Schaffer F
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1038-44. PubMed ID: 10752939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of "systemic" budesonide concentrations on in vitro allergen-induced activation of blood mononuclear cells isolated from asthmatic patients.
    Oddera S; Silvestri M; Sacco O; Lantero S; Morelli MC; Rossi GA
    Allergy; 1995 May; 50(5):397-404. PubMed ID: 7573828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected.
    Kita H; Jorgensen RK; Reed CE; Dunnette SL; Swanson MC; Bartemes KR; Squillace D; Blomgren J; Bachman K; Gleich GJ
    J Allergy Clin Immunol; 2000 Sep; 106(3):521-9. PubMed ID: 10984373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciclesonide modulates in vitro allergen-driven activation of blood mononuclear cells and allergen-specific T-cell blasts.
    Silvestri M; Morandi F; Pistoia V; Prigione I; Rossi GA
    Immunol Lett; 2012 Jan; 141(2):190-6. PubMed ID: 22015638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy attenuates eosinophil transendothelial migration induced by the supernatants of antigen-stimulated mononuclear cells from atopic asthmatics.
    Nagata M; Saito K; Kikuchi I; Tabe K; Hagiwara K; Kanazawa M; Sakamoto Y
    Int Arch Allergy Immunol; 2004 Jun; 134 Suppl 1():21-4. PubMed ID: 15166479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.